Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: (milestone) I don't see how anyone reading these PR's released today

I would say in about 2-3 years. How's that for an answer.

No licenses for at least 2 years? I find that difficult to believe.

Then this should help with revenues:

it is apparent we have a solution that resonates with this audience. This is in large part due to improvements and additions to CDX that were completed in March of this year, making it a truly enterprise level offering with broader appeal. Our recent press release announcing our reseller relationship with SRA is one of the tangible results in validation of CDX and the generation of partner interest

.

.

.

Be well

Share
New Message
Please login to post a reply